Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Vertex Pharmaceuticals (VRTX) stock is sliding after the company said it won't advance its pain treatment into the next phase ...

Anthropic says Claude Opus 4.1 improves software engineering accuracy to 74.5%. That compares to 62.3% with Claude Sonnet 3.7 and 72.5% with Claude Opus 4. More specifically, the updated model is ...

The company also said Veo 3 Fast, the faster and more economical version of Veo 3, will also be generally available on Veo 3 ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here’s what to ...

Anthropic, on Tuesday, announced a new version of its AI model, the Claude Opus 4.1, just as rival OpenAI is getting close to ...

A Massachusetts biotech working on a class of medicines called circular RNA therapeutics beat out companies from around the ...

Google Cloud is doubling down on its commitment to empower India’s global capability centres (GCCs) with AI infrastructure ...

EVERSANA – which is pharmaphorum's parent company – said that The AI Agency has been set up in collaboration with Google and draws on the tech giant's validated, compliant, and powerful AI, including ...

Experts weigh in on how generative AI is shaking up the video game industry, from development to characters' dialogue.